Skip to main content

Year: 2021

Panostaja Oyj – Invitation to the Annual General Meeting

Panostaja Oyj   Stock Exchange Bulletin, Invitation to General Meeting    December 16, 2021, 11:00 am INVITATION TO THE ANNUAL GENERAL MEETING Panostaja Oyj’s Annual General Meeting will be held on Monday February 7, 2022 at 1:00 pm at Technopolis Asemakeskus, Aava conference room, Peltokatu 26, Tampere. Shareholders of the company may participate in the meeting and exercise their rights as shareholders only through voting in advance as well as by making counterproposals and presenting questions in advance. It is not possible to attend the meeting in person at the meeting venue due to COVID-19 pandemic. Instructions for shareholders are presented in this notice under section C Instructions for the participants in the General Meeting. The Board of Directors of the Company has resolved on the exceptional procedure for the meeting based on...

Continue reading

Form 8.5 (EPT/RI) Tungsten Corporation Plc

FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)   1.        KEY INFORMATION  (a)        Name of exempt principal trader: Shore Capital Stockbrokers Ltd(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree Tungsten Corporation plc(c)        Name of the party to the offer with which exempt principal trader is connected: Tungsten Corporation plc(d)        Date dealing undertaken: 15 December 2021(e)        Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer? No  2.        DEALINGS BY THE EXEMPT PRINCIPAL TRADER   (a)        Purchases...

Continue reading

Child Resistance Packaging Market to grow at ~ 5.4% CAGR during the forecast period (2022-2030) – Report by Market Research Future (MRFR)

New York, Dec. 16, 2021 (GLOBE NEWSWIRE) — Child Resistance Packaging Market Overview: According to a comprehensive research report by Market Research Future (MRFR), “Child Resistance Packaging Market Information by Type (Reclosable Packaging, Non-reclosable Packaging, Special Blister Packaging), By End-Use (Personal Care, Chemicals, Pharmaceuticals) and By Region – Forecast to 2030.”, the market is projected to generate market growth at 5.4% CAGR for the forecast period of 2022 to 2030. List of the companies profiled in the global Beverage Cans Market research report are –O.Berk Company, LLC (US) Sun Grown Packaging (US) MJS Packaging Inc. (US) MJS Packaging Inc.(US) Kaufman Container (US) Amcor Limited (Australia) Ecobliss B.V. (Netherlands) Bemis Company, Inc. (US) Global Closure System (France) WestRock Company (US) Among...

Continue reading

Orthopaedic Summit 2021 Conference: Dr. Isador Lieberman presents the benefits of ready-to-use for the US market

  Orthopaedic Summit 2021 Conference: Dr. Isador Lieberman presents the benefits of ready-to-use for the US market         Eragny-sur-Oise, Fleurieux-sur-l’Arbresle, France, December 10th, 2021 17h45 CET – Safe (FR0013467123 – ALSAF), a company specializing in the design, manufacturing and marketing of single-use technologies for spinal surgeries, delivering the safest treatment for spinal fractures urgently treated, announces the presentation of the benefits of Safe Orthopaedics’ ready-to-use technologies at the Orthopaedic Summit 2021 in Las Vegas, USA. Safe Orthopaedics has launched the distribution of its technologies in the United States in early 2021, where a sales manager has been recruited. Safe Orthopaedics relies on a few strategic centers to demonstrate the medico-economic benefits of its technologies and works...

Continue reading

Hexagon Purus awarded contracts for complete vehicle integration of hydrogen-powered heavy-duty trucks for two North American truck manufacturers

  Hexagon Purus has been contracted by two major truck manufacturers in North America to deliver complete vehicle integration of two Hydrogen-powered class 8 trucks. The total sales value is approximately USD 2.2 million (approx. NOK 20 million). Driving energy transformation Hexagon Purus will assemble and deliver the complete trucks which involve integration of an electric drivetrain, a fuel cell module as well as the Hexagon Purus ProCabTM Hydrogen Storage system and Hexagon Purus ProPackTM high energy density Li-ion battery packs. “The momentum for zero emission mobility continues to strengthen. We see growing interest in our fuel cell electric drivetrain technologies, and hydrogen will play an important role in the future of trucking,” says Todd Sloan, EVP Systems, Hexagon Purus. “We are pleased to be selected by major OEMs once again...

Continue reading

Hexagon Purus awarded contracts for complete vehicle integration of hydrogen-powered heavy-duty trucks for two North American truck manufacturers

Hexagon Purus has been contracted by two major truck manufacturers in North America to deliver complete vehicle integration of two Hydrogen-powered class 8 trucks. The total sales value is approximately USD 2.2 million (approx. NOK 20 million). Driving energy transformation Hexagon Purus will assemble and deliver the complete trucks which involve integration of an electric drivetrain, a fuel cell module as well as the Hexagon Purus ProCabTM Hydrogen Storage system and Hexagon Purus ProPackTM high energy density Li-ion battery packs. “The momentum for zero emission mobility continues to strengthen. We see growing interest in our fuel cell electric drivetrain technologies, and hydrogen will play an important role in the future of trucking,” says Todd Sloan, EVP Systems, Hexagon Purus. “We are pleased to be selected by major OEMs once again...

Continue reading

HONKARAKENNE’S PUBLICATION SCHEDULE FOR FINANCIAL REPORTING IN 2022

HONKARAKENNE OYJ    Stock Exchange Release   16 December 2021 at 9:15 a.m. HONKARAKENNE’S PUBLICATION SCHEDULE FOR FINANCIAL REPORTING IN 2022 Honkarakenne will publish its financial results for year 2021 on Wednesday 16 February 2022. Half year financial report for January – June 2022 will be published on Wednesday 24 August 2022. Complete Financial Statements for 2021 will be published on the company’s website www.honka.com at latest on Wednesday in week 12 in 2022. Honkarakenne Oyj’s Annual General Meeting is scheduled to be held on Wednesday 13 April 2022. The Board of Directors will later issue a separate invitation to the Annual General Meeting. Honkarakenne Oyj Marko SaarelainenPresident and CEO FURTHER INFORMATIONMarko Saarelainen, President and CEO, tel. +358 40 542 0254, marko.saarelainen@honka.comMaarit Jylhä, Vice President...

Continue reading

8 Metaverse Tokens You Could Invest In: Get a Good Return on Your Investment

Investing can be a lucrative way to make money. One of the great ways to invest is by purchasing tokens. Many people don’t know what tokens are and how they work, which means that it can be hard for them to find out where they should put their money. You must be thinking, what is the best way to get a good return on your investment? One option that can provide a great return is investing in cryptocurrencies. There are many different types of digital currencies out there, including Metaverse tokens. Now the question arises which are excellent Metaverse tokens are the best to invest in? To help you know this, here I have listed the best Metaverse tokens names on which you can invest blindly to gain profit. Decentraland (MANA)The Decentraland platform is a revolutionary virtual gaming platform that operates under the Ethereum blockchain....

Continue reading

Verona Pharma Reports TQT Study Successfully Demonstrated No Clinically Relevant Effect on Cardiac Conduction

Study Supports Ongoing Phase 3 Program and Planned NDA Submission LONDON and RALEIGH, N.C., Dec. 16, 2021 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, today announces ensifentrine met all safety objectives in a thorough QT (“TQT”) study designed to evaluate effects, if any, of ensifentrine on cardiac conduction in healthy individuals. No clinically relevant changes in measures of cardiac conduction including QTcF, PR and QRS intervals were observed with either 3 mg or 9 mg inhaled ensifentrine dose at any time point over 24 hours. The U.S. Food and Drug Administration (“FDA”) requires a TQT study to support most New Drug Applications for potential new medications. The protocol was reviewed by the FDA prior to commencing the study,...

Continue reading

Cornish Metals Releases Unaudited Financial Statements and Management’s Discussion and Analysis for the Nine Months Ended October 31, 2021

VANCOUVER, British Columbia, Dec. 16, 2021 (GLOBE NEWSWIRE) — Cornish Metals Inc. (TSX-V/AIM: CUSN) (“Cornish Metals” or the “Company”), a mineral exploration and development company focused on its projects in Cornwall, United Kingdom, is pleased to announce that it has released its unaudited financial statements and management’s discussion and analysis (“MD&A”) for the nine months ended October 31, 2021. The reports are available under the Company’s profile on SEDAR (www.sedar.com) and on the Company’s website. Highlights for the nine months ended October 31, 2021 and for the period ending December 15, 2021 (All figures expressed in Canadian dollars unless otherwise stated)Completion of listing and concurrent financing on AIM in February 2021 raising gross proceeds of £8.2 million ($14.4 million based on closest available...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.